Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
American Well (AMWL)
NYSE:AMWL
Holding AMWL?
Track your performance easily
Earnings Data
Report Date
Feb 20, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$2.93Last Year’s EPS
-$3.4Same Quarter Last Year
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 30, 2024
|% Change Since: -18.55%
|Next Earnings Date:Feb 20, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of achievements, such as important milestones with the Defense Health Agency and an improved EBITDA outlook, alongside challenges including flat revenue growth and decreased visit numbers. While there is positive momentum in strategic initiatives, immediate financial results remain under pressure.Company Guidance
During the Amwell Q3 2024 earnings call, the company provided several key metrics and guidance updates. Total revenue for the quarter was reported at $61 million, which remained flat compared to the same period last year. Subscription revenue was $26.2 million, reflecting a 5% decrease from the previous quarter. Amwell completed approximately 1.4 million visits in Q3, which marked a 4.6% decrease from the previous year. The average revenue per visit increased by 7% to $83. The company revised its full-year 2024 revenue guidance to a range of $247 million to $252 million and improved its adjusted EBITDA guidance to a range of negative $142 million to $137 million. Amwell expects to achieve cash flow positivity by 2026, with plans for significant subscription revenue growth and a continued focus on cost alignment strategies.Defense Health Agency Milestone
Amwell reached an important milestone by completing the second phase of modernizing the military health system for the Defense Health Agency with Converge scheduled visits now live. An enterprise-wide deployment is planned by the end of 2024.
Improved EBITDA Guidance
Amwell improved its EBITDA guidance for 2024, with adjusted EBITDA now expected to be between negative $142 million and $137 million, better than the previous range of negative $150 million to $145 million.
Strong Balance Sheet
The company ended Q3 with $245 million in cash and marketable securities and no debt, highlighting its financial strength.
Notable Client Wins
Amwell secured expansions with Stanford Health and Wellstar for virtual nursing and a sizable win with Capital Blue Cross for integrating the Sword Health Musculoskeletal Program.
---
AMWL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AMWL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $9.65 | $9.16 | -5.08% |
| Jul 31, 2024 | $8.01 | $11.23 | +40.20% |
| May 01, 2024 | $10.62 | $10.40 | -2.07% |
| Feb 14, 2024 | $22.20 | $26.20 | +18.02% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does American Well (AMWL) report earnings?
American Well (AMWL) is schdueled to report earning on Feb 20, 2025, TBA Not Confirmed.
What is American Well (AMWL) earnings time?
American Well (AMWL) earnings time is at Feb 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AMWL EPS forecast?
AMWL EPS forecast for the fiscal quarter 2024 (Q4) is -$2.93.
---